| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.72e-04 | 75 | 138 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.19e-04 | 43 | 138 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.44e-04 | 18 | 138 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 2.82e-04 | 4 | 138 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 4.68e-04 | 5 | 138 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 6.49e-04 | 57 | 138 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 6.52e-04 | 100 | 138 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 6.65e-04 | 25 | 138 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | single-stranded DNA 3'-5' DNA exonuclease activity | 6.98e-04 | 6 | 138 | 2 | GO:0008310 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.89e-04 | 60 | 138 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 8.37e-04 | 27 | 138 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 8.37e-04 | 27 | 138 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.32e-04 | 28 | 138 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 9.73e-04 | 7 | 138 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 9.73e-04 | 7 | 138 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.07e-03 | 65 | 138 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.07e-03 | 65 | 138 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.26e-03 | 31 | 138 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.29e-03 | 8 | 138 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | adenosine receptor binding | 1.29e-03 | 8 | 138 | 2 | GO:0031685 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 1.29e-03 | 8 | 138 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.29e-03 | 8 | 138 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.48e-03 | 120 | 138 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.64e-03 | 73 | 138 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | anaphase-promoting complex binding | 1.65e-03 | 9 | 138 | 2 | GO:0010997 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.00e-03 | 77 | 138 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 2.06e-03 | 10 | 138 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | single-stranded DNA exodeoxyribonuclease activity | 2.06e-03 | 10 | 138 | 2 | GO:0008297 | |
| GeneOntologyMolecularFunction | ubiquitin ligase activator activity | 2.06e-03 | 10 | 138 | 2 | GO:1990757 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.11e-03 | 37 | 138 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.28e-03 | 38 | 138 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 2.41e-03 | 81 | 138 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ADGRL1 GRIN2A GRIN2B DBN1 DSCAML1 TENM3 PTPRO DCHS1 PLEC CDH3 CDH11 | 3.00e-03 | 599 | 138 | 11 | GO:0050839 |
| GeneOntologyBiologicalProcess | heart development | AKAP6 ERBB2 CAD IFT172 ZDHHC16 PCDHA10 NEB RYR2 NEDD4 SETDB2 ADAMTS6 SCN5A ALPK3 DCHS1 LRP2 MMP2 PLEC CDH11 | 2.52e-06 | 757 | 136 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB2 RELN MYOC ADGRL1 GRIN2A GRIN2B DBN1 GRM5 NEDD4 TENM3 CAMKV PTPRO ARC LRP5 PLEC CDC20 CDH3 TNS1 CDH11 PLXNB1 | 6.12e-06 | 974 | 136 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 1.61e-05 | 278 | 136 | 10 | GO:0031503 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.62e-05 | 180 | 136 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse maturation | 3.25e-05 | 10 | 136 | 3 | GO:0090129 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.44e-05 | 187 | 136 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 RELN ADGRL1 GRIN2A GRIN2B DBN1 GRM5 NEDD4 TENM3 CAMKV PTPRO ARC LRP5 CDC20 PLXNB1 | 4.75e-05 | 685 | 136 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 5.91e-05 | 12 | 136 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | AKAP6 DPP6 RELN CHRNA9 MYOC GRIN2A GRIN2B DBN1 GRM5 RYR2 NEDD4 GLRA2 SCN5A | 8.56e-05 | 559 | 136 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | RELN PDE4A LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 CAMKV GLRA2 ARC CDC20 CDH11 | 1.26e-04 | 663 | 136 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | RELN PDE4A LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 CAMKV GLRA2 ARC CDC20 CDH11 | 1.28e-04 | 664 | 136 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | DNA replication proofreading | 1.29e-04 | 3 | 136 | 2 | GO:0045004 | |
| GeneOntologyBiologicalProcess | positive regulation of anaphase-promoting complex-dependent catabolic process | 1.29e-04 | 3 | 136 | 2 | GO:1905786 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DMXL2 RELN PDE4A CHRNA9 LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 SLC12A4 CAMKV GLRA2 ARC CDC20 CDH11 | 1.37e-04 | 931 | 136 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DMXL2 RELN PDE4A CHRNA9 LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 SLC12A4 CAMKV GLRA2 ARC CDC20 CDH11 | 1.37e-04 | 931 | 136 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 1.52e-04 | 41 | 136 | 4 | GO:0070286 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DMXL2 RELN PDE4A CHRNA9 LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 SLC12A4 CAMKV GLRA2 ARC CDC20 CDH11 | 1.52e-04 | 939 | 136 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | developmental maturation | RELN MYOC ADGRL1 TDRD1 ADAMTS12 BSPH1 DCHS1 MMP2 CDC20 CDH3 PLXNB1 | 1.61e-04 | 439 | 136 | 11 | GO:0021700 |
| GeneOntologyBiologicalProcess | embryo development | CHRNA9 IFT172 POLE INPP5K LAMA2 GRIN2B DBN1 ECSIT TDRD1 LRP1B DSCAML1 RYR2 DNAAF2 SETDB1 SETDB2 CDC40 EIF2S2 DCHS1 LRP2 LRP5 DMBT1 FUT8 | 1.77e-04 | 1437 | 136 | 22 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 1.83e-04 | 43 | 136 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 2.23e-04 | 83 | 136 | 5 | GO:0048168 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 2.25e-04 | 130 | 136 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.36e-04 | 313 | 136 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | synaptic signaling | DMXL2 RELN PDE4A CHRNA9 LAMA2 GRIN2A GRIN2B DBN1 GRM5 NEDD4 GRIP1 SLC12A4 CAMKV GLRA2 ARC CDC20 CDH11 | 2.39e-04 | 976 | 136 | 17 | GO:0099536 |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 2.57e-04 | 4 | 136 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 4.12e-04 | 53 | 136 | 4 | GO:1903115 | |
| GeneOntologyBiologicalProcess | N-glycan fucosylation | 4.26e-04 | 5 | 136 | 2 | GO:0036071 | |
| GeneOntologyBiologicalProcess | positive regulation of AMPA receptor activity | 4.26e-04 | 5 | 136 | 2 | GO:2000969 | |
| GeneOntologyBiologicalProcess | regulation of anaphase-promoting complex-dependent catabolic process | 4.26e-04 | 5 | 136 | 2 | GO:1905784 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 4.35e-04 | 147 | 136 | 6 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase A signaling | 4.51e-04 | 23 | 136 | 3 | GO:0010738 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 4.75e-04 | 55 | 136 | 4 | GO:0014037 | |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 5.13e-04 | 24 | 136 | 3 | GO:0036158 | |
| GeneOntologyBiologicalProcess | anaphase-promoting complex-dependent catabolic process | 5.80e-04 | 25 | 136 | 3 | GO:0031145 | |
| GeneOntologyBiologicalProcess | induction of bacterial agglutination | 6.36e-04 | 6 | 136 | 2 | GO:0043152 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell communication | 6.36e-04 | 6 | 136 | 2 | GO:0086068 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell signaling | 6.36e-04 | 6 | 136 | 2 | GO:0086029 | |
| GeneOntologyCellularComponent | anaphase-promoting complex | 1.46e-05 | 23 | 138 | 4 | GO:0005680 | |
| GeneOntologyCellularComponent | dendritic spine | 3.38e-05 | 242 | 138 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 3.96e-05 | 247 | 138 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ERBB2 CHRNA9 GRIN2A GRIN2B DBN1 GRM5 GRIP1 PTPRO GLRA2 ARC AKAP1 | 8.03e-05 | 405 | 138 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | RAVE complex | 1.29e-04 | 3 | 138 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | synaptic membrane | ERBB2 CHRNA9 ADGRL1 GRIN2A GRIN2B DBN1 GRM5 GRIP1 TENM3 PTPRO GLRA2 ARC AKAP1 | 1.32e-04 | 583 | 138 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | mitotic checkpoint complex | 2.57e-04 | 4 | 138 | 2 | GO:0033597 | |
| GeneOntologyCellularComponent | axon | RELN CAD MYOC POLG ADGRL1 GRIN2A GRIN2B DBN1 DSCAML1 TRAK1 GRIP1 TENM3 PTPRO SCN5A LRP2 PLEC | 2.68e-04 | 891 | 138 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear ubiquitin ligase complex | 3.06e-04 | 49 | 138 | 4 | GO:0000152 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.84e-04 | 201 | 138 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | terminal bouton | 4.40e-04 | 96 | 138 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | dynein complex | 4.45e-04 | 54 | 138 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CHRNA9 GRIN2A GRIN2B DBN1 GRM5 HNRNPA2B1 GRIP1 PTPRO GLRA2 ARC AKAP1 | 5.18e-04 | 503 | 138 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.82e-04 | 25 | 138 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | distal axon | 6.36e-04 | 435 | 138 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.30e-04 | 378 | 138 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | U2-type catalytic step 2 spliceosome | 1.11e-03 | 31 | 138 | 3 | GO:0071007 | |
| GeneOntologyCellularComponent | catenin complex | 1.21e-03 | 32 | 138 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DPP6 RELN CAD ENC1 LAMA2 GRIN2A GRIN2B DBN1 GRM5 CPNE5 HNRNPA2B1 TRAK1 NEDD4 GRIP1 PTPRO LRP2 ARC PLEC | 1.22e-03 | 1228 | 138 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.24e-03 | 317 | 138 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.33e-03 | 33 | 138 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.51e-03 | 9 | 138 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | neuronal ribonucleoprotein granule | 1.88e-03 | 10 | 138 | 2 | GO:0071598 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.88e-03 | 10 | 138 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | DPP6 ERBB2 SGIP1 CHRNA9 GRIN2A GRIN2B SCN5A DCHS1 LRP5 C8A CATSPERG CDH3 CDH11 | 2.11e-03 | 785 | 138 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | cytoplasmic region | 2.73e-03 | 360 | 138 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.73e-03 | 12 | 138 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 2.87e-03 | 212 | 138 | 6 | GO:0031461 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ADGRL1 GRIN2A GRIN2B DBN1 GRM5 HNRNPA2B1 NEDD4 GRIP1 TENM3 CAMKV PTPRO ARC CDH11 | 2.98e-03 | 817 | 138 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | ERBB2 CHRNA9 LAMA2 GRIN2A GRIN2B DBN1 GRM5 HNRNPA2B1 NEDD4 GRIP1 CAMKV PTPRO GLRA2 ARC AKAP1 | 3.00e-03 | 1018 | 138 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 3.22e-03 | 13 | 138 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 3.26e-03 | 45 | 138 | 3 | GO:0099524 | |
| GeneOntologyCellularComponent | axonal growth cone | 3.26e-03 | 45 | 138 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | Z disc | 3.30e-03 | 151 | 138 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | brush border | 3.40e-03 | 152 | 138 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.90e-03 | 157 | 138 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 3.92e-03 | 97 | 138 | 4 | GO:0071013 | |
| GeneOntologyCellularComponent | dendrite | RELN LAMA2 GRIN2A GRIN2B DBN1 GRM5 TRAK1 NEDD4 GRIP1 PTPRO LRP2 ARC PLEC | 4.50e-03 | 858 | 138 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | RELN LAMA2 GRIN2A GRIN2B DBN1 GRM5 TRAK1 NEDD4 GRIP1 PTPRO LRP2 ARC PLEC | 4.59e-03 | 860 | 138 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | Prp19 complex | 4.89e-03 | 16 | 138 | 2 | GO:0000974 | |
| GeneOntologyCellularComponent | I band | 4.94e-03 | 166 | 138 | 5 | GO:0031674 | |
| Domain | - | 3.27e-07 | 39 | 134 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.02e-07 | 46 | 134 | 6 | IPR011042 | |
| Domain | WD40 | DMXL2 IFT172 CDC20B NUP214 EML3 DMXL1 CDC40 WDR97 PRPF19 CDC20 | 2.39e-05 | 268 | 134 | 10 | SM00320 |
| Domain | WD40_repeat | DMXL2 IFT172 CDC20B NUP214 EML3 DMXL1 CDC40 WDR97 PRPF19 CDC20 | 2.72e-05 | 272 | 134 | 10 | IPR001680 |
| Domain | - | DMXL2 IFT172 CDC20B NUP214 EML3 DMXL1 CDC40 WDR97 PRPF19 CDC20 PLXNB1 | 2.87e-05 | 333 | 134 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DMXL2 IFT172 CDC20B NUP214 EML3 DMXL1 CDC40 WDR97 PRPF19 CDC20 PLXNB1 | 3.03e-05 | 335 | 134 | 11 | IPR015943 |
| Domain | Rav1p_C | 5.11e-05 | 2 | 134 | 2 | IPR022033 | |
| Domain | Rav1p_C | 5.11e-05 | 2 | 134 | 2 | PF12234 | |
| Domain | WD40_repeat_dom | DMXL2 IFT172 CDC20B EML3 DMXL1 CDC40 TENM3 WDR97 PRPF19 CDC20 | 5.71e-05 | 297 | 134 | 10 | IPR017986 |
| Domain | WD40 | 1.07e-04 | 259 | 134 | 9 | PF00400 | |
| Domain | Ldl_recept_b | 1.24e-04 | 14 | 134 | 3 | PF00058 | |
| Domain | LDLRB | 1.24e-04 | 14 | 134 | 3 | PS51120 | |
| Domain | Cadherin_CS | 1.35e-04 | 109 | 134 | 6 | IPR020894 | |
| Domain | Cdc20/Fizzy | 1.53e-04 | 3 | 134 | 2 | IPR033010 | |
| Domain | NMDAR2_C | 1.53e-04 | 3 | 134 | 2 | PF10565 | |
| Domain | NMDAR2_C | 1.53e-04 | 3 | 134 | 2 | IPR018884 | |
| Domain | LY | 1.54e-04 | 15 | 134 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.54e-04 | 15 | 134 | 3 | IPR000033 | |
| Domain | CADHERIN_1 | 1.64e-04 | 113 | 134 | 6 | PS00232 | |
| Domain | Cadherin | 1.64e-04 | 113 | 134 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.72e-04 | 114 | 134 | 6 | PS50268 | |
| Domain | - | 1.72e-04 | 114 | 134 | 6 | 2.60.40.60 | |
| Domain | CA | 1.81e-04 | 115 | 134 | 6 | SM00112 | |
| Domain | WD_REPEATS_1 | 1.82e-04 | 278 | 134 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.87e-04 | 279 | 134 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.87e-04 | 279 | 134 | 9 | PS50294 | |
| Domain | LDLR_class-A_CS | 1.89e-04 | 40 | 134 | 4 | IPR023415 | |
| Domain | Cadherin-like | 1.90e-04 | 116 | 134 | 6 | IPR015919 | |
| Domain | Cadherin | 2.08e-04 | 118 | 134 | 6 | IPR002126 | |
| Domain | Ldl_recept_a | 3.00e-04 | 45 | 134 | 4 | PF00057 | |
| Domain | Glyco_hydro_31_CS | 3.04e-04 | 4 | 134 | 2 | IPR030459 | |
| Domain | Gal_mutarotase_N | 3.04e-04 | 4 | 134 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 3.04e-04 | 4 | 134 | 2 | PF16863 | |
| Domain | - | 3.27e-04 | 46 | 134 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.86e-04 | 48 | 134 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.18e-04 | 49 | 134 | 4 | IPR002172 | |
| Domain | LDLa | 4.18e-04 | 49 | 134 | 4 | SM00192 | |
| Domain | LDLRA_2 | 4.18e-04 | 49 | 134 | 4 | PS50068 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 5.04e-04 | 5 | 134 | 2 | PS00707 | |
| Domain | TUDOR | 5.76e-04 | 23 | 134 | 3 | PS50304 | |
| Domain | Cadherin_C | 7.40e-04 | 25 | 134 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 7.40e-04 | 25 | 134 | 3 | IPR000233 | |
| Domain | Glyco_hydro_31_AS | 7.52e-04 | 6 | 134 | 2 | IPR030458 | |
| Domain | EGF_extracell | 9.05e-04 | 60 | 134 | 4 | IPR013111 | |
| Domain | EGF_2 | 9.05e-04 | 60 | 134 | 4 | PF07974 | |
| Domain | TUDOR | 9.31e-04 | 27 | 134 | 3 | SM00333 | |
| Domain | Glyco_hydro_31 | 1.05e-03 | 7 | 134 | 2 | IPR000322 | |
| Domain | Pre-SET | 1.05e-03 | 7 | 134 | 2 | PF05033 | |
| Domain | Glyco_hydro_31 | 1.05e-03 | 7 | 134 | 2 | PF01055 | |
| Domain | PreSET | 1.05e-03 | 7 | 134 | 2 | SM00468 | |
| Domain | Pre-SET_dom | 1.05e-03 | 7 | 134 | 2 | IPR007728 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.05e-03 | 7 | 134 | 2 | PS00129 | |
| Domain | PRE_SET | 1.05e-03 | 7 | 134 | 2 | PS50867 | |
| Domain | TSP_1 | 1.09e-03 | 63 | 134 | 4 | PF00090 | |
| Domain | Catenin_binding_dom | 1.15e-03 | 29 | 134 | 3 | IPR027397 | |
| Domain | - | 1.15e-03 | 29 | 134 | 3 | 4.10.900.10 | |
| Domain | TSP1 | 1.22e-03 | 65 | 134 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.22e-03 | 65 | 134 | 4 | IPR000884 | |
| Domain | TSP1 | 1.22e-03 | 65 | 134 | 4 | PS50092 | |
| Domain | Tudor | 1.27e-03 | 30 | 134 | 3 | IPR002999 | |
| Domain | DHC_N1 | 1.39e-03 | 8 | 134 | 2 | PF08385 | |
| Domain | P_TREFOIL_1 | 1.39e-03 | 8 | 134 | 2 | PS00025 | |
| Domain | Trefoil | 1.39e-03 | 8 | 134 | 2 | PF00088 | |
| Domain | P_trefoil_CS | 1.39e-03 | 8 | 134 | 2 | IPR017957 | |
| Domain | Dynein_heavy_dom-1 | 1.39e-03 | 8 | 134 | 2 | IPR013594 | |
| Domain | P_TREFOIL_2 | 1.78e-03 | 9 | 134 | 2 | PS51448 | |
| Domain | PD | 1.78e-03 | 9 | 134 | 2 | SM00018 | |
| Domain | EGF-like_dom | 2.15e-03 | 249 | 134 | 7 | IPR000742 | |
| Domain | NHL_repeat | 2.21e-03 | 10 | 134 | 2 | IPR001258 | |
| Domain | NHL | 2.21e-03 | 10 | 134 | 2 | PF01436 | |
| Domain | ANF_lig-bd_rcpt | 2.35e-03 | 37 | 134 | 3 | IPR001828 | |
| Domain | ANF_receptor | 2.35e-03 | 37 | 134 | 3 | PF01094 | |
| Domain | EGF_1 | 2.46e-03 | 255 | 134 | 7 | PS00022 | |
| Domain | - | 2.69e-03 | 11 | 134 | 2 | 4.10.110.10 | |
| Domain | MBD | 2.69e-03 | 11 | 134 | 2 | SM00391 | |
| Domain | MBD | 2.69e-03 | 11 | 134 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 2.69e-03 | 11 | 134 | 2 | IPR001739 | |
| Domain | MBD | 2.69e-03 | 11 | 134 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 2.69e-03 | 11 | 134 | 2 | IPR016177 | |
| Domain | Peripla_BP_I | 2.73e-03 | 39 | 134 | 3 | IPR028082 | |
| Domain | EGF-like_CS | 2.80e-03 | 261 | 134 | 7 | IPR013032 | |
| Domain | EGF_2 | 3.05e-03 | 265 | 134 | 7 | PS01186 | |
| Domain | P_trefoil_dom | 3.22e-03 | 12 | 134 | 2 | IPR000519 | |
| Domain | OLF | 3.78e-03 | 13 | 134 | 2 | PF02191 | |
| Domain | OLF | 3.78e-03 | 13 | 134 | 2 | PS51132 | |
| Domain | - | 3.78e-03 | 13 | 134 | 2 | 2.10.10.10 | |
| Domain | NHL | 3.78e-03 | 13 | 134 | 2 | PS51125 | |
| Domain | Olfac-like_dom | 3.78e-03 | 13 | 134 | 2 | IPR003112 | |
| Domain | OLF | 3.78e-03 | 13 | 134 | 2 | SM00284 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.39e-03 | 14 | 134 | 2 | IPR024317 | |
| Domain | FN_type2_col-bd | 4.39e-03 | 14 | 134 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.39e-03 | 14 | 134 | 2 | PS51092 | |
| Domain | Dynein_HC_stalk | 4.39e-03 | 14 | 134 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.39e-03 | 14 | 134 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.39e-03 | 14 | 134 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | FN2_1 | 4.39e-03 | 14 | 134 | 2 | PS00023 | |
| Domain | TUDOR | 4.39e-03 | 14 | 134 | 2 | PF00567 | |
| Domain | MT | 4.39e-03 | 14 | 134 | 2 | PF12777 | |
| Domain | AAA_8 | 4.39e-03 | 14 | 134 | 2 | PF12780 | |
| Pubmed | FUT10 ERBB2 DMXL2 RPS6KA4 DNAH2 CPNE5 LRP1B DMXL1 NEDD4 ADAMTS12 ADAMTS6 DNAH17 LRP2 USP4 MMP2 SSH2 | 4.62e-08 | 730 | 140 | 16 | 34857952 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 21521618 | ||
| Pubmed | Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life. | 6.38e-08 | 3 | 140 | 3 | 28865018 | |
| Pubmed | 2.44e-07 | 14 | 140 | 4 | 19240213 | ||
| Pubmed | DMXL2 PDE4A CAD SGIP1 GRIN2A GRIN2B DBN1 GRM5 NEDD4 CAMKV ANAPC1 DCHS1 ARC SMARCC1 SSH2 TNS1 CDH11 | 3.69e-07 | 963 | 140 | 17 | 28671696 | |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 9004271 | ||
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 6.35e-07 | 5 | 140 | 3 | 17229826 | |
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 33310066 | ||
| Pubmed | 1.72e-06 | 272 | 140 | 9 | 31010829 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 27939943 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 25482201 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 21664258 | ||
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 2.21e-06 | 7 | 140 | 3 | 16438943 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 31178125 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 PDE4A ARSJ POLE POLG ADGRL1 BTAF1 NUP214 EML3 TRAK1 SLC12A4 PCNX4 SCN5A ARC LRP5 LRRC14 PLEC | 2.41e-06 | 1105 | 140 | 17 | 35748872 |
| Pubmed | 2.68e-06 | 214 | 140 | 8 | 22199357 | ||
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 18606955 | ||
| Pubmed | Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry. | 3.52e-06 | 8 | 140 | 3 | 26960431 | |
| Pubmed | DPP6 DMXL2 CAD SGIP1 PTDSS1 ADGRL1 GRIN2A GRIN2B DBN1 GRM5 HNRNPA2B1 MGAT3 CAMKV EIF2S2 PRPF19 USP4 SSH2 PLEC TNS1 | 5.03e-06 | 1431 | 140 | 19 | 37142655 | |
| Pubmed | 5.29e-06 | 62 | 140 | 5 | 19367581 | ||
| Pubmed | 6.77e-06 | 322 | 140 | 9 | 26514267 | ||
| Pubmed | The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. | 7.50e-06 | 10 | 140 | 3 | 18997788 | |
| Pubmed | Stable MCC binding to the APC/C is required for a functional spindle assembly checkpoint. | 7.50e-06 | 10 | 140 | 3 | 24464857 | |
| Pubmed | The PP2AB56 phosphatase promotes the association of Cdc20 with APC/C in mitosis. | 1.03e-05 | 11 | 140 | 3 | 28404789 | |
| Pubmed | 1.03e-05 | 11 | 140 | 3 | 24639464 | ||
| Pubmed | CAD DNAH2 PIWIL4 NUP214 HNRNPA2B1 SETDB2 SLC12A4 PCNX4 DCHS1 SMARCC1 DMBT1 TRIM47 AKAP1 | 1.21e-05 | 754 | 140 | 13 | 35906200 | |
| Pubmed | Conformation-specific anti-Mad2 monoclonal antibodies for the dissection of checkpoint signaling. | 1.37e-05 | 12 | 140 | 3 | 26986935 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22851698 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25131300 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23723061 | ||
| Pubmed | Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. | 1.61e-05 | 2 | 140 | 2 | 30850015 | |
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 1.61e-05 | 2 | 140 | 2 | 20921396 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 1.61e-05 | 2 | 140 | 2 | 16901514 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21611838 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20696923 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23618906 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15010472 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19474217 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 1.61e-05 | 2 | 140 | 2 | 26179233 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24857654 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 1.61e-05 | 2 | 140 | 2 | 16033900 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 38214768 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21503117 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18372311 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32247039 | ||
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 1.61e-05 | 2 | 140 | 2 | 29764972 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27605622 | ||
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 1.61e-05 | 2 | 140 | 2 | 33043365 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30355491 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12127670 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20890276 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16045501 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27915379 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11030144 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32179753 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16944113 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9822733 | ||
| Pubmed | N-Glycoform-dependent interactions of megalin with its ligands. | 1.61e-05 | 2 | 140 | 2 | 27773703 | |
| Pubmed | NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. | 1.61e-05 | 2 | 140 | 2 | 15742215 | |
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 1.61e-05 | 2 | 140 | 2 | 26289036 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21310164 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24090193 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37657442 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 38813758 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18591651 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22179607 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36968271 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 1.61e-05 | 2 | 140 | 2 | 38731978 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30269991 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31498792 | ||
| Pubmed | Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons. | 1.61e-05 | 2 | 140 | 2 | 32191258 | |
| Pubmed | Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. | 1.61e-05 | 2 | 140 | 2 | 31807283 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26500840 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27015584 | ||
| Pubmed | Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. | 1.61e-05 | 2 | 140 | 2 | 15210733 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19806658 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22142193 | ||
| Pubmed | Genetic analysis in post-mortem samples with micro-ischemic alterations. | 1.61e-05 | 2 | 140 | 2 | 28086167 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33976221 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10771476 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22334046 | ||
| Pubmed | MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts. | 1.61e-05 | 2 | 140 | 2 | 19578738 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27480812 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34197904 | ||
| Pubmed | Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. | 1.61e-05 | 2 | 140 | 2 | 16157280 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34830255 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27345410 | ||
| Pubmed | NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease. | 1.61e-05 | 2 | 140 | 2 | 36232696 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20356844 | ||
| Pubmed | Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors. | 1.61e-05 | 2 | 140 | 2 | 22306487 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36038077 | ||
| Pubmed | ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. | 1.61e-05 | 2 | 140 | 2 | 22378040 | |
| Pubmed | Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior. | 1.61e-05 | 2 | 140 | 2 | 23201971 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11719203 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16266783 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23766685 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27839871 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22187052 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17569088 | ||
| GeneFamily | WD repeat domain containing | 1.06e-05 | 262 | 96 | 9 | 362 | |
| GeneFamily | Low density lipoprotein receptors | 3.99e-05 | 13 | 96 | 3 | 634 | |
| GeneFamily | Dyneins, axonemal | 9.35e-05 | 17 | 96 | 3 | 536 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 5.76e-04 | 7 | 96 | 2 | 1201 | |
| GeneFamily | Tudor domain containing | 9.89e-04 | 37 | 96 | 3 | 780 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.49e-03 | 11 | 96 | 2 | 1025 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 2.09e-03 | 13 | 96 | 2 | 434 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.50e-03 | 19 | 96 | 2 | 50 | |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_DN | 1.14e-05 | 200 | 138 | 8 | M3983 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 1.79e-05 | 279 | 138 | 9 | M16867 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 DPP6 RALGDS RELN ENC1 ADGRL1 NEB GRM5 CPNE5 LRP1B DSCAML1 RYR2 GRIP1 WDR97 PTPRO GLRA2 SSH2 CATSPERG | 2.12e-05 | 1106 | 138 | 18 | M39071 |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 3.36e-05 | 115 | 138 | 6 | M40201 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 3.40e-05 | 233 | 138 | 8 | M13273 | |
| Coexpression | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN | 3.93e-05 | 13 | 138 | 3 | M2070 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | RELN SGIP1 ENC1 ADGRL1 SLC12A4 TENM3 DCHS1 ARC MMP2 CDH3 TNS1 | 4.85e-05 | 479 | 138 | 11 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | RELN SGIP1 ENC1 ADGRL1 SLC12A4 TENM3 DCHS1 ARC MMP2 CDH3 TNS1 | 5.23e-05 | 483 | 138 | 11 | MM1082 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 137 | 140 | 8 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-08 | 137 | 140 | 8 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-07 | 181 | 140 | 8 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-07 | 130 | 140 | 7 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.98e-07 | 195 | 140 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.05e-07 | 196 | 140 | 8 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-07 | 160 | 140 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-07 | 160 | 140 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.55e-06 | 178 | 140 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.16e-06 | 187 | 140 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 196 | 140 | 7 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 196 | 140 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.95e-06 | 196 | 140 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.05e-06 | 197 | 140 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.05e-06 | 197 | 140 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.05e-06 | 197 | 140 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 198 | 140 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 198 | 140 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.15e-06 | 198 | 140 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.26e-06 | 199 | 140 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-06 | 199 | 140 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-06 | 199 | 140 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-06 | 200 | 140 | 7 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-06 | 200 | 140 | 7 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 6.91e-06 | 146 | 140 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.47e-06 | 148 | 140 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-06 | 150 | 140 | 6 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.07e-06 | 150 | 140 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.73e-06 | 155 | 140 | 6 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-05 | 158 | 140 | 6 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 159 | 140 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 168 | 140 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 169 | 140 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-05 | 176 | 140 | 6 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 140 | 6 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 140 | 6 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 177 | 140 | 6 | 75049e5372d14edeb5768339359396b73a85c2cc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 178 | 140 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.20e-05 | 179 | 140 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 2.27e-05 | 180 | 140 | 6 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 2.34e-05 | 181 | 140 | 6 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 181 | 140 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 182 | 140 | 6 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.42e-05 | 182 | 140 | 6 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 182 | 140 | 6 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 182 | 140 | 6 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.49e-05 | 183 | 140 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 184 | 140 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 185 | 140 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.65e-05 | 185 | 140 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 185 | 140 | 6 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 185 | 140 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 186 | 140 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.73e-05 | 186 | 140 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.73e-05 | 186 | 140 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 186 | 140 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 187 | 140 | 6 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-05 | 187 | 140 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.90e-05 | 188 | 140 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 188 | 140 | 6 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 188 | 140 | 6 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 188 | 140 | 6 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 188 | 140 | 6 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 188 | 140 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 189 | 140 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 189 | 140 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 189 | 140 | 6 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.99e-05 | 189 | 140 | 6 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.99e-05 | 189 | 140 | 6 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.99e-05 | 189 | 140 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-05 | 190 | 140 | 6 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.08e-05 | 190 | 140 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.08e-05 | 190 | 140 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-05 | 191 | 140 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.17e-05 | 191 | 140 | 6 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 191 | 140 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.17e-05 | 191 | 140 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 191 | 140 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.17e-05 | 191 | 140 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.26e-05 | 192 | 140 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-05 | 192 | 140 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 193 | 140 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-05 | 193 | 140 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 193 | 140 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-05 | 193 | 140 | 6 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.36e-05 | 193 | 140 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.36e-05 | 193 | 140 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 193 | 140 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 193 | 140 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 193 | 140 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.46e-05 | 194 | 140 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.46e-05 | 194 | 140 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.46e-05 | 194 | 140 | 6 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-05 | 194 | 140 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| Drug | ciguatoxin 3C | 2.07e-06 | 5 | 136 | 3 | ctd:C466858 | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.20e-06 | 199 | 136 | 9 | 4294_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.33e-06 | 200 | 136 | 9 | 4364_DN | |
| Drug | kynurenic acid | 8.79e-06 | 122 | 136 | 7 | CID000003845 | |
| Drug | avermectin | 9.84e-06 | 48 | 136 | 5 | CID006450460 | |
| Drug | WT702 | 1.14e-05 | 8 | 136 | 3 | CID000089643 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 1.18e-05 | 24 | 136 | 4 | CID003645780 | |
| Drug | memantine | 1.29e-05 | 86 | 136 | 6 | CID000004054 | |
| Drug | NS3763 | 1.71e-05 | 9 | 136 | 3 | CID004359312 | |
| Drug | L-689,560 | 1.92e-05 | 27 | 136 | 4 | CID000121918 | |
| Drug | AC1L1ICP | 2.43e-05 | 10 | 136 | 3 | CID000004520 | |
| Drug | AC1NUW3V | 2.58e-05 | 29 | 136 | 4 | CID005462126 | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 136 | 8 | 5393_DN | |
| Drug | pilocarpine- | 2.95e-05 | 147 | 136 | 7 | CID000004819 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 2.96e-05 | 30 | 136 | 4 | CID000001226 | |
| Drug | NPC 12626 | 3.38e-05 | 31 | 136 | 4 | CID000108099 | |
| Drug | LY235959 | 3.38e-05 | 31 | 136 | 4 | CID000131938 | |
| Drug | eliprodil | 3.38e-05 | 31 | 136 | 4 | CID000060703 | |
| Drug | cyclopentylcarbamoylphosphonic acid | 3.54e-05 | 2 | 136 | 2 | CID010198038 | |
| Drug | YoYo-3 | 3.54e-05 | 2 | 136 | 2 | CID006444584 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 3.85e-05 | 32 | 136 | 4 | CID000001222 | |
| Drug | oriens | 3.98e-05 | 154 | 136 | 7 | CID000161645 | |
| Drug | galloylglucose | 5.71e-05 | 13 | 136 | 3 | CID000124375 | |
| Drug | monomethyl phthalate | DPP6 MGAM ERBB2 CAD ANPEP MYOC SETDB2 SLC12A4 ASAH1 EIF2S2 ARC SMARCC1 USP4 CDC20 FUT8 DEDD CDH11 | 5.81e-05 | 957 | 136 | 17 | ctd:C517284 |
| Drug | C6H12NO5P | 6.18e-05 | 36 | 136 | 4 | CID000104962 | |
| Drug | gabapentin | 7.17e-05 | 169 | 136 | 7 | CID000003446 | |
| Drug | AC1L9FMM | 7.66e-05 | 73 | 136 | 5 | CID000444055 | |
| Drug | GAMs | 7.68e-05 | 38 | 136 | 4 | CID000002935 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 5.63e-06 | 8 | 139 | 3 | DOID:1561 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 1.02e-05 | 29 | 139 | 4 | EFO_0008009 | |
| Disease | Ventricular Fibrillation, Paroxysmal Familial, 1 | 2.20e-05 | 2 | 139 | 2 | C2751898 | |
| Disease | VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO | 2.20e-05 | 2 | 139 | 2 | C4017668 | |
| Disease | Paroxysmal familial ventricular fibrillation | 2.20e-05 | 2 | 139 | 2 | cv:C0340493 | |
| Disease | Alcoholic Intoxication, Chronic | 4.21e-05 | 268 | 139 | 8 | C0001973 | |
| Disease | Autism Spectrum Disorders | 5.23e-05 | 85 | 139 | 5 | C1510586 | |
| Disease | heart valve disease (is_marker_for) | 6.59e-05 | 3 | 139 | 2 | DOID:4079 (is_marker_for) | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 6.59e-05 | 3 | 139 | 2 | C0349788 | |
| Disease | Schizophrenia | RELN PDE4A LAMA2 GRIN2A GRIN2B DBN1 GRM5 TRAK1 ADAMTS12 SETDB1 ASAH1 LRP2 ARC FUT8 | 7.69e-05 | 883 | 139 | 14 | C0036341 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.48e-05 | 49 | 139 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 9.23e-05 | 477 | 139 | 10 | C0005586 | |
| Disease | Paroxysmal familial ventricular fibrillation | 1.31e-04 | 4 | 139 | 2 | C0340493 | |
| Disease | intraocular pressure measurement | RELN TTC41P ANPEP MYOC KBTBD7 NEDD4 ADAMTS6 ANAPC1 TNS1 CDH11 | 1.56e-04 | 509 | 139 | 10 | EFO_0004695 |
| Disease | ligament rupture | 2.18e-04 | 5 | 139 | 2 | EFO_1002012 | |
| Disease | alcohol consumption measurement | AKAP6 DPP6 MGAM RELN CAD SGIP1 IFT172 DNAH2 GRIN2B GRM5 CPNE5 GRIP1 SDHAF2 FUT8 CDH11 KLB | 2.58e-04 | 1242 | 139 | 16 | EFO_0007878 |
| Disease | RS-warfarin measurement | 3.59e-04 | 128 | 139 | 5 | EFO_0803325 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 3.78e-04 | 30 | 139 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | bitter alcoholic beverage consumption measurement | 4.28e-04 | 133 | 139 | 5 | EFO_0010092 | |
| Disease | Colorectal Carcinoma | AKAP6 RALGDS CAD POLE GRIN2A DSCAML1 BUB1B DCHS1 LRP2 MMP2 DNAH8 | 5.10e-04 | 702 | 139 | 11 | C0009402 |
| Disease | heart function measurement | 5.50e-04 | 34 | 139 | 3 | EFO_0004311 | |
| Disease | pack-years measurement, systolic blood pressure | 5.50e-04 | 34 | 139 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Malignant neoplasm of breast | AKAP6 ERBB2 INPP5K LAMA2 DNAJC21 PHF7 NUP214 DBN1 NEDD4 EIF2S2 MMP2 RMND1 TNS1 PLXNB1 | 5.66e-04 | 1074 | 139 | 14 | C0006142 |
| Disease | placental insufficiency (biomarker_via_orthology) | 6.06e-04 | 8 | 139 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | household income | 6.16e-04 | 304 | 139 | 7 | EFO_0009695 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 6.20e-04 | 398 | 139 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | asparaginase-induced acute pancreatitis | 7.76e-04 | 9 | 139 | 2 | EFO_1001507 | |
| Disease | epilepsy (implicated_via_orthology) | 1.07e-03 | 163 | 139 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | DNA methylation | 1.13e-03 | 656 | 139 | 10 | GO_0006306 | |
| Disease | Tachycardia, Ventricular | 1.18e-03 | 11 | 139 | 2 | C0042514 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.18e-03 | 11 | 139 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Cognitive impairment | 1.18e-03 | 11 | 139 | 2 | HP_0100543 | |
| Disease | vascular dementia (is_marker_for) | 1.18e-03 | 11 | 139 | 2 | DOID:8725 (is_marker_for) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Long QT Syndrome | 1.18e-03 | 11 | 139 | 2 | C0023976 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.26e-03 | 45 | 139 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Abnormality of refraction | AKAP6 LAMA2 PCDHA11 PCDHA10 GRIN2A GRIN2B DSCAML1 NEDD4 FER1L4 MMP2 | 1.36e-03 | 673 | 139 | 10 | HP_0000539 |
| Disease | corneal resistance factor | 1.38e-03 | 451 | 139 | 8 | EFO_0010067 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.41e-03 | 257 | 139 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Metabolic Bone Disorder | 1.93e-03 | 14 | 139 | 2 | C0005944 | |
| Disease | Diabetic Neuralgia | 1.93e-03 | 14 | 139 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.93e-03 | 14 | 139 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.93e-03 | 14 | 139 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.93e-03 | 14 | 139 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.93e-03 | 14 | 139 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.93e-03 | 14 | 139 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.93e-03 | 14 | 139 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.93e-03 | 14 | 139 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.93e-03 | 14 | 139 | 2 | C0393835 | |
| Disease | Drug habituation | 2.18e-03 | 115 | 139 | 4 | C0013170 | |
| Disease | Drug abuse | 2.18e-03 | 115 | 139 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.18e-03 | 115 | 139 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.18e-03 | 115 | 139 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.18e-03 | 115 | 139 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.18e-03 | 115 | 139 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.18e-03 | 115 | 139 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.18e-03 | 115 | 139 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.18e-03 | 115 | 139 | 4 | C0029231 | |
| Disease | cognitive decline measurement | 2.20e-03 | 486 | 139 | 8 | EFO_0007710 | |
| Disease | Osteopenia | 2.22e-03 | 15 | 139 | 2 | C0029453 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.22e-03 | 15 | 139 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Substance abuse problem | 2.25e-03 | 116 | 139 | 4 | C0740858 | |
| Disease | refractive error, age at onset, Myopia | 2.25e-03 | 193 | 139 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Cocaine-Related Disorders | 2.32e-03 | 117 | 139 | 4 | C0236736 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.36e-03 | 195 | 139 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Myopia | 2.39e-03 | 385 | 139 | 7 | HP_0000545 | |
| Disease | myopia (is_implicated_in) | 2.53e-03 | 16 | 139 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 2.62e-03 | 121 | 139 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 2.86e-03 | 17 | 139 | 2 | C0153943 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.86e-03 | 17 | 139 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.86e-03 | 17 | 139 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.86e-03 | 17 | 139 | 2 | C0154060 | |
| Disease | Acute myeloid leukemia | 2.86e-03 | 17 | 139 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.86e-03 | 17 | 139 | 2 | 601626 | |
| Disease | t-tau measurement | 3.03e-03 | 126 | 139 | 4 | EFO_0004760 | |
| Disease | Cocaine Abuse | 3.12e-03 | 127 | 139 | 4 | C0009171 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 3.57e-03 | 19 | 139 | 2 | DOID:2876 (is_marker_for) | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 3.77e-03 | 66 | 139 | 3 | EFO_0007708 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.96e-03 | 20 | 139 | 2 | DOID:3328 (is_marker_for) | |
| Disease | susceptibility to mononucleosis measurement | 4.27e-03 | 69 | 139 | 3 | EFO_0008403 | |
| Disease | Cocaine Dependence | 4.30e-03 | 139 | 139 | 4 | C0600427 | |
| Disease | Stomach Carcinoma | 4.36e-03 | 21 | 139 | 2 | C0699791 | |
| Disease | refractive error | 4.57e-03 | 326 | 139 | 6 | MONDO_0004892 | |
| Disease | C-reactive protein measurement | AKAP6 DMXL2 CAD ZNF573 SGIP1 IFT172 ETV6 GRM5 EML3 NLRP3 CAMKV DNAH17 KIAA2012 | 4.66e-03 | 1206 | 139 | 13 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSYDGSENLSRFWY | 111 | C9J7I0 | |
| DQWYRASVLAYASEE | 556 | Q9BXT4 | |
| LAQFYISWAEEYEAR | 151 | O60566 | |
| AVQVDYYLDEERAWA | 201 | P24298 | |
| YYLDEERAWALDVAE | 206 | P24298 | |
| VTETEEIWYLLEGSY | 531 | Q6ZRH7 | |
| ETLEEITGYLYISAW | 401 | P04626 | |
| SLVERGLAQWVDSYY | 886 | Q92667 | |
| IRNDYYLNLVDWSSG | 181 | Q12834 | |
| EFYWYVDEGLSADNL | 376 | Q9P2K9 | |
| YNGEWRELRYDSTCE | 181 | P07357 | |
| TLTEYASWEDYVAAR | 186 | O94910 | |
| EYLRQVGGSEEYWLS | 226 | Q7LC44 | |
| TWYKDDTELDRYCGL | 311 | Q96L96 | |
| ESLLSDFDYWDYVVP | 26 | Q96D03 | |
| YLTWDRDQYDGLDSI | 91 | Q9UGM1 | |
| DLWLNEGFASYVEYL | 406 | P15144 | |
| SLDVYELDAKQGRWY | 301 | Q13510 | |
| QSYIWIGEEYDRESK | 2696 | Q8TDJ6 | |
| SELTYLDAFWRDYIN | 251 | O75618 | |
| RDQDGYYWITGRIDD | 556 | Q9NR19 | |
| AYWILEDYSGALETL | 1776 | Q9Y485 | |
| KRDLDGSEDWVYYRI | 81 | P58397 | |
| SEGDDYYINGAWTID | 761 | Q9UKP5 | |
| YKLYWREVGAEEEAN | 661 | Q8TDY8 | |
| AGNEYWIYSASTLER | 536 | P08253 | |
| TGSDDDWEYLLNSDY | 701 | Q9H1A4 | |
| TDLDEEYTDNWLAVY | 291 | P32926 | |
| LWDYVYQLLSDSRYE | 341 | P41212 | |
| VDADSGYNAWLSYEL | 596 | Q9Y5I1 | |
| VAGEEELRGSYNWDY | 3151 | Q96JQ0 | |
| LGSSNLYFLSDDDWE | 51 | Q8IY49 | |
| GWADRYDVTDGYQRE | 306 | P41594 | |
| WTDARSDAIYSALYD | 1441 | Q9NZR2 | |
| VDSEYYNSLRWILEN | 1096 | P46934 | |
| WIADDYLRTFLTQDG | 286 | Q09327 | |
| VRENYTWSQDYTDLE | 186 | Q8IVD9 | |
| WYYGVNNDSLEERLF | 611 | Q9NVR5 | |
| YGYLSWGQALEEEEE | 41 | Q5FYB0 | |
| SLDWDSQVELYRAYV | 1366 | O43451 | |
| GSLDWDSQVELYRAY | 2261 | O43451 | |
| LASQYEVDGYNAWRD | 1351 | A9Z1Z3 | |
| ANDLTIDYADQRLYW | 806 | O75197 | |
| IDYADQRLYWTDLDT | 811 | O75197 | |
| YLEEYERDWYIGLVS | 1051 | Q63HM2 | |
| LDYQYDTPGLWELEE | 891 | O43157 | |
| QEILDTLEDNRDWYY | 666 | P27815 | |
| TLEDNRDWYYSAIRQ | 671 | P27815 | |
| IDRNAENWCYYEGLE | 251 | Q6N069 | |
| SISGYYEILWGDVDI | 1291 | Q96JB1 | |
| WERYLAEAQGTYEEL | 441 | P54098 | |
| YSWGGYTDIDLAVDE | 371 | Q99972 | |
| LEVYFEPEDYLNWRS | 21 | Q0VF49 | |
| YLSYIEEWDLVLAAS | 306 | P35658 | |
| DTWVRYLGYANEVGE | 16 | Q9UDX5 | |
| DLTIDDSYWYRIVAS | 2221 | P24043 | |
| YDESCDLWSLGVILY | 586 | O75676 | |
| RNLYWTDYALETIEV | 1521 | P98164 | |
| VDRSDGYVYWVDDSL | 2241 | P98164 | |
| GYVYWVDDSLDIIAR | 2246 | P98164 | |
| LTLDYEEDLLYWVDA | 2556 | P98164 | |
| IREESAADWALYTYE | 21 | Q16643 | |
| DFDIRAILDWDYYIE | 1121 | Q07864 | |
| YEYDTREDQWINIGT | 586 | Q8WVZ9 | |
| AAYDVLSDPQERAWY | 51 | Q5F1R6 | |
| AWAGSERDYTYEELL | 166 | P20042 | |
| YTAQDEWALDSIYIG | 1016 | P78509 | |
| WEQAGEYSRAVDCYL | 1286 | Q9UG01 | |
| LLYISWTYGDDTTDL | 646 | Q16827 | |
| VDADSGYNAWLSYEL | 596 | Q9Y5I2 | |
| ATGDYLLSSSDDQYW | 316 | Q9UMS4 | |
| YDAWFDYLRLVESDA | 491 | Q9BZJ0 | |
| AEYLSQEEYEAWSQR | 856 | Q9BXL6 | |
| EVFDWILDQGYYSER | 106 | Q8NCB2 | |
| YRRLIYWECTDDGEA | 96 | Q075Z2 | |
| LSDLWDQEQYDSEYS | 1826 | O14981 | |
| SFERYSYLWTDNLQE | 986 | Q9UFH2 | |
| ALRWYLATGDDIYDV | 56 | Q8TD84 | |
| DSDDRLYEAYVEWKL | 341 | Q6P4F1 | |
| RDVNDYVSYAWVGDS | 371 | Q9BT40 | |
| ATTDSDLDYDYLQNW | 761 | P55287 | |
| QWNDSRLAYSEYPDD | 101 | P23416 | |
| WLGYENESALNLYET | 96 | Q12967 | |
| TGLRNDYYLNILDWS | 226 | Q86Y33 | |
| SLLDGFEWQDAYTIR | 461 | Q86Z14 | |
| WLYYDYTNDLSIELD | 261 | Q8N4M1 | |
| DERLVYESAINWISY | 206 | O14682 | |
| ETLSLDWVYGYRGRD | 246 | Q32P44 | |
| EGVIYNGLSDWLYEE | 281 | P42658 | |
| TYPDVGLSYEDWDRS | 856 | Q9Y3R0 | |
| VLDDVRCSGYESYLW | 426 | Q9UGM3 | |
| LDDVRCSGYESYLWS | 926 | Q9UGM3 | |
| YGEYDLSTNEWTDGI | 2131 | Q9P225 | |
| LSLYLDEYEETPWDA | 4021 | Q9P225 | |
| DDWDRRLLTTYINDY | 4051 | Q9P225 | |
| YNEEFTWRLGENYAE | 126 | Q1HG43 | |
| DYLLRVQESISDFYW | 3876 | Q92736 | |
| DQDQDYDYLNEWGSR | 801 | P22223 | |
| QLDLEYVRSGWDNYE | 331 | Q9BQ95 | |
| AEWYDPNASLLRRYE | 11 | Q9Y5B8 | |
| NGDYDRTIKVEVYDW | 241 | Q9HCH3 | |
| DRLINEPSNDWDIYY | 106 | Q9NX18 | |
| DEDVYRLWLDGYSVT | 16 | O43427 | |
| LDWASGTLYQDRFDY | 241 | Q96P20 | |
| DLYYLSQTDGAGDWR | 166 | Q9BYC5 | |
| DRYWPTADGRLVEYD | 121 | P52788 | |
| ALDRGTYYWEVEIIE | 476 | Q96LD4 | |
| WREQAALDLYPYDAG | 176 | Q9BUD6 | |
| LYDSEEDIRSYWDLE | 761 | Q7LBE3 | |
| WELEPGAFSDLYQRY | 231 | Q9BWX1 | |
| RDSLDNSYYDWYILV | 406 | Q8IVG5 | |
| AYDRYLKLWDTETGQ | 351 | O60508 | |
| YNNRTYSIDDIDWSV | 306 | Q7Z3Z4 | |
| VDSEATRNEWYDFYL | 756 | Q7Z3Z4 | |
| WESLDLYLSDPENYL | 301 | Q14524 | |
| YWDRENLEGLYDKTC | 376 | Q9NWS8 | |
| WDDGESIDTYERDLY | 1726 | P14410 | |
| IYPYSSSQDDEEWLR | 206 | Q92922 | |
| DYDNLEGLSWVDYGE | 16 | Q9UP95 | |
| RAGTELTWDYNYEVG | 1256 | Q15047 | |
| RNGEVVEAWYGSDEY | 616 | Q13023 | |
| LRADTIYGYDHDDWL | 56 | Q9UPV9 | |
| YDEYEDGDLSSWINR | 211 | Q96JJ7 | |
| DELRGEAGYYLTTWF | 486 | Q6ZS11 | |
| IYWDPADDLAADIYS | 156 | Q8TCY9 | |
| RTELTWDYGYEAGTV | 686 | Q96T68 | |
| SLDGQWYSYDDSTVE | 676 | Q70EL4 | |
| WYSYDDSTVEPLRED | 681 | Q70EL4 | |
| DWDSETRRLYYDEQE | 741 | Q13107 | |
| EWEYLDPNQRDLYRD | 41 | Q86YE8 | |
| VASDYWYILEVADAG | 26 | A6NFC5 | |
| TEDGYFLRAWNYTVD | 91 | Q5JS37 | |
| ETTEESLRNYYEQWG | 31 | P22626 | |
| DEEATDLLAYWNDTY | 361 | Q76I76 | |
| GFYAEIDWERYNSPE | 66 | Q9BQI5 | |
| WEAEGYNLVLDSDLY | 6 | A6NE52 | |
| QYEGESWRESARYLE | 46 | Q92791 | |
| TYREGKLARWEYDES | 241 | O75063 | |
| DYNTSDPLIRWDSYD | 326 | Q9HBL0 | |
| GGEDTILYSWDLRSY | 306 | A0A1W2PR48 | |
| WNVLLEAGYDVSEAY | 766 | Q6P2S7 | |
| VGYEYESCLDLTLWE | 1081 | Q9P273 | |
| REALEAESAWCYLYG | 3811 | Q15149 | |
| ALWAGYSVDRLYELT | 816 | P27708 | |
| YGSWDLFREAYAAIE | 216 | Q969W1 | |
| YWLDPNLRYATREAD | 131 | P48651 | |
| VVDLVGYRAGWYDEE | 146 | Q9BRZ2 | |
| VLWTTDIYGRLAADY | 476 | Q15048 | |
| LISVSYDDWDYSLEA | 276 | Q12879 | |
| YDDWDYSLEARVRDG | 281 | Q12879 | |
| SYDEWDYGLPARVRD | 281 | Q13224 | |
| YDLQSDNLYKSDLEW | 3376 | P20929 | |
| YDLQSDNVYRADLEW | 4346 | P20929 |